Pakistan, June 22 -- A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks.
After France on Friday became the latest country to allow all doctors, rather than just specialists, to prescribe these drugs, here are some key questions about them.
How do they work?
The most well-known of this new wave of drugs are Danish pharma firm Novo Nordisk's Ozempic and Wegovy, as well as US company Eli Lilly's Mounjaro.
These drugs enhance the action of a hormone in the pancreas called "glucagon-like peptide 1", or GLP-1, the name given to this family of medications.
The hormone affects the secretion of insulin, so was first targeted to...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.